Cytokinetics, Incorporated (CYTK) forecast

Cytokinetics, Incorporated (CYTK) forecast: price $62.55, trailing P/E -8.72, forward P/E 85.80. How to read the street's path.

The live CYTK price is $62.55. Trailing P/E is -8.72 and forward P/E is 85.80. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the CYTK forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full CYTK quote · Dividends · Price prediction · Academy

Questions